Olipudase alfa
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Olipudase alfa, covering 2021-02-01 to 2025-10-31. Get the full timeline:
Most recent: Clinical Trial Update: A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)